Ex Parte MiyasakaDownload PDFPatent Trial and Appeal BoardJul 25, 201713700361 (P.T.A.B. Jul. 25, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/700,361 05/31/2013 Susumu Miyasaka H-NS-01219 (1502-798PCTUS 4361 54964 7590 07/27/2017 rVwiHie.n f.Senniaer Powers;^ EXAMINER Attn: IP Legal Department 15 Hampshire Street KLEIN, BENJAMIN JACOB Mansfield, MA 02048 ART UNIT PAPER NUMBER 3761 NOTIFICATION DATE DELIVERY MODE 07/27/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): iplegalus@covidien.com uspatents @ senniger.com medtronic_mitg-pmr_docketing@cardinal-ip.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte SUSUMU MIYASAKA1 Appeal 2015-003799 Application 13/700,361 Technology Center 3700 Before WILLIAM A. CAPP, SCOTT A. DANIELS, and SEAN P. O’HANLON, Administrative Patent Judges. DANIELS, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Susumu Miyasaka (Appellant) appeals under 35 U.S.C. § 134(a) from the Final Rejection of claims 1—20. Appeal Br. 3. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 According to Appellant the Real Party In Interest is Covidien LP. App. Br. 1. Appeal 2015-003799 Application 13/700,361 CLAIMED SUBJECT MATTER Appellant claims a connector cap “used in priming of a transfusion line which conducts a fluid such as liquid medicine to a patient.” Spec. 11. Priming of a transfusion line ensures that any gas, air for example, is removed from the delivery line prior to the liquid medicine being dispensed to a patient. See id. 1 52, (“When the fluid . . . enters the reservoir 13, air from the tube 5 and the flow path of the male connector 40 is exhausted.”). Appellant’s cap 10 includes cylindrical housing 11 having septum 21 at one end and hydrophobic filter 31 at the other end defining reservoir 13 within the cap. Id. 143 44. i o FIG. 3D Figure 3D, above, illustrates connector cap 10 for use in priming of a transfusion line. Septum 21 is made of an elastic material having slit 22 formed in it. Id. 143. Slit 22 accepts tube part 43 of male connector 40 as shown below in Figure 4 from the ’361 application. Id. 1 50. 2 Appeal 2015-003799 Application 13/700,361 Figure 4 shows a schematic cross-sectional diagram illustrating the connected state of a male connector and connector cap. Id. 119. In use, when tube part 43 of male connector 40 is inserted through septum 21 as illustrated above in Figure 4 of the ’361 application, fluid can flow between tube part 43 and reservoir 13. Id. 143. Also, air can pass through hydrophobic filter 31, but liquid cannot. Id. When tube part 43 is removed from septum 21, the nature of the septum’s elastic material permits slit 22 to close, thus sealing fluid drawn into the cap within reservoir 13. Id. 154. Claim 1, reproduced below, is illustrative of the claimed subject matter: 1. A connector cap which can be removably attached to a male connector, comprising: a container including a first opening and a second opening and having an inside and an outside; a seal member disposed in the first opening so as to separate the inside and the outside of the container, the seal member including an insertion passage formed therethrough whereby an inserted body can be inserted from the outside to the inside 3 Appeal 2015-003799 Application 13/700,361 of the container, the insertion passage of the seal member elastically sealed after removal of the inserted body; and a hydrophobic filter which is disposed in the second opening. REJECTION Claims 1—20 are rejected under 35 U.S.C. § 103(a) as being unpatentable over Ramsey (US 2007/0156118 Al, pub. July 5, 2007), in view of Miyasaka (US 2008/0103487 Al, pub. May 1, 2008). ANALYSIS Unpatentability of claims 1—20 over Ramsey and Miyasaka Appellant argues the two independent claims 1 and 7 as a group. See App. Br. 8—12. Appellant does not present separate arguments as to dependent claims 2—6 and 8—20, which depend respectively from claim 1 and claim 7. Id. at 12. We select claim 1 as representative of the group where claim 7 stands or falls with claim 1. See 37 C.F.R. 41.37(c)(l)(vii) (2011). Claims 1 and 7 The Examiner found that Ramsey discloses a removable connector cap for priming a medical intravenous line for example, including container 68 having seal member(s) 92, 94 and insertion passage 70 at one end for accepting a male member and a hydrophobic filter at the opposite end of the container. Final Act. 4. The Examiner determined that seal member 92, 94 “separate [s] the inside and the outside of the container” as recited in claim 1. Id.', Ans. 3. According to the Examiner, Miyasaka teaches use of an elastic septum seal 27 that is widely known in the art. Ans. 4. The Examiner states that a person of ordinary skill in the art would have known “to replace the O-ring seal of Ramsey with any alternative type 4 Appeal 2015-003799 Application 13/700,361 of seal, including the septum seal of Miyasaka,” because it is merely the replacement of one well know element for another that achieves the same functionality and predictable outcome. Id. Appellant makes three specific arguments: first, that the Examiner’s analysis fails to address each element of the claims; second, that the Examiner has not identified an articulated reason with evidentiary underpinnings to support the combination of Ramsey and Miyasaka; and lastly, that the modification of Ramsey with Miyasaka’s septum seal would render Ramsey unsatisfactory for its intended purpose. App. Br. 3, 8—12. We address each of the arguments, below, in turn. Appellant argues specifically that Ramsey’s O-ring seal 94 fails to meet the limitation of a seal that “separate^]” the inside and outside of the container. Id. at 8. Appellant’s position is also that Ramsey’s O-ring seal 94 is disposed around opening 70, “and is not disposed in the opening 70.” Id. The clause at issue in claim 1 recites “a seal member disposed in the first opening so as to separate the inside and the outside of the container.” Observing Figures 5—8 of Ramsey we observe certain end structure (no specific reference number) located, i.e. disposed, in a first end of container 68 and O-ring seal 94 formed on an outer surface of that end structure. We have highlighted in yellow the end structure to which we refer, in Ramsey’s Figure 8, as reproduced below. 5 Appeal 2015-003799 Application 13/700,361 Figure 8 from Ramsey, as annotated above, illustrates priming cap 66 and container 68 with end structure highlighted in yellow, including O-ring seal 94. The Examiner takes the position that this end structure which includes O-ring seal 94 is “disposed in the first opening” as called for in claim 1. Ans. 2—3. We are persuaded that the Examiner’s position is more reasonable because the claimed “opening,” as the noun in this prepositional phrase, is really nothing more than a temporal reference to an end of the container that is not in fact “open” but has the seal member positioned in it. Also, we understand from a plain reading of the claim that the seal member is “disposed in the first opening,” with no further elucidation of the relative structural arrangement of the “opening” and “seal member.” Appellant’s argument does not persuasively address the Examiner’s complete analysis which points to the end structure as well as O-ring seal 94 6 Appeal 2015-003799 Application 13/700,361 (as highlighted above) being located in the first end of Ramsey’s container. A reasonable reading of the claim language does not differentiate sufficiently the recited opening and seal member from Ramsey’s end structure and O-ring seal 94 at the end of container 68. In this same vein, we agree with the Examiner that the claim language “does not require that the separation completely and totally isolates the inside from the outside of the container.” Id. at 3. Ramsey arguably has an opening 70 which is not elastic and does not self-seal; however, observing Figure 8, above, Ramsey’s end structure and O-ring seal 94 forms the end of container 68 and mostly separates the inside from the outside of container 68. See Ramsey 129, Figs. 5—8. We are also not persuaded that the Examiner has provided insufficient reasoning and evidence that one of ordinary skill in the art would have combined Ramsey and Miyasaka. See App. Br. 9—10. Appellant argues that the “Examiner failed to cite to any portion of Ramsey that would provide motivation” for utilizing a septum in Ramsey. Id, at 9. There is, however, no legal requirement that the Examiner’s reasoning or rationale be predicated on “a suggestion” in the references. See KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 419 (2007) (“The obviousness analysis cannot be confined by a formalistic conception of the words teaching, suggestion, and motivation, or by overemphasis on the importance of published articles and the explicit content of issued patents.”). Moreover, the Examiner pointed to paragraph 33 of Ramsey which, after describing the embodiment of Figure 5, states that “[w]ith this configuration, the seal may be formed as an integral part of the reservoir device. However, other types of seals may be devised 7 Appeal 2015-003799 Application 13/700,361 and used.” See Ans. 4 (citing Ramsey 133). Thus, Ramsey expresses the evidentiary foundation that alternative seal structures were known in the art. Also, the Examiner explained that “[sjeptum seals are extremely well known in the art and clearly taught by Miyasaka.” Final Act. 2. The Examiner reasoned persuasively that [t] he use of a septum type seal provides for a sealed space prior to the introduction of any medical fluids, thereby maintaining a sterile and uncontaminated environment. One of ordinary skill would recognize that the septum seal of Miyasaka would provide additional protection against contamination, while still providing a suitable seal engageable by the distal end of a syringe or other male sealing element. Id. In light of the record, Appellant’s arguments do not apprise us of any lack of reasoning or failure on the part of the Examiner to provide sufficient evidentiary foundation for the combination of Ramsey and Miyasaka. Appellant’s argument that Miyasaka’s septum seal would prevent fluid from flowing into the reservoir device 68 of Ramsey’s priming cap, during priming, and therefore Ramsey’s priming cap would thereupon be made unfit for its intended purpose, is unpersuasive. See App. Br. 10-11. Appellant’s argument presumes that one of ordinary skill in the art would not have known, or gleaned from Miyasaka, to insert male member through slit 27a of septum 27 to allow fluid to flow into Ramsey’s reservoir device 68. See id. We find the Examiner’s position here the more persuasive one where he explained that [u] se of the septum seal of Miyasaka would only require that the seal be penetrated by the male member prior to the beginning of priming, and would remain in that configuration for the duration of priming, thereby allowing fluid flow between the luer element (50) and the reservoir. 8 Appeal 2015-003799 Application 13/700,361 Ans. 6. Indeed, in the Final Office Action the Examiner stated the specific teaching from Miyasaka, and that one of ordinary skill in the art would have understood from such teaching, to use a penetrating member with an elastic septum seal: Miyasaka et al. teaches a connection structure for a transfusion line set comprising an elastic septum (27) defining an inside and an outside of a connector element, designed to allow the passage of a penetrating element of a male connector from the outside to the inside, and which elastically seals before and after insertion of the penetrating element. Final Act. 9. Appellant’s argument does not substantively address, nor provide persuasive evidence, why use of a penetrating member as shown in Miyasaka used with an elastic seal, for example in Figure 4, would have been outside the experience or knowledge of one of ordinary skill in the art. Besides the fact that a penetrating member in cooperation with the elastic septum seal is expressly disclosed in Miyasaka, we are not apprised of any evidence that using such a penetrating member was beyond the level of ordinary skill in the art. See KSR Int’l Co. v. Teleflex, Inc., 550 U.S. 398, 416—19 (2007) (holding obvious the inclusion of a known device because there was no evidence presented that the inclusion of the known device in the combined device was “uniquely challenging or difficult for one of ordinary skill in the art” or “represented an unobvious step over the prior art”). The Examiner’s position is supported by a preponderance of the evidence and the Examiner’s legal conclusion of obviousness is well founded and articulated. We sustain the rejection of claim 1. Appellant does not raise what amounts to a separate argument for the patentability of claim 7. See Appeal Br. 8—12. We sustain the rejection of 9 Appeal 2015-003799 Application 13/700,361 claim 7 for the same reasons as stated for claim 1. See 37 C.F.R. § 41.37(c)(iv) (failure to separately argue claims). Claims 2—6 and 8—20 Appellant argues that dependent claims 2—6 are allowable due to their dependency from claim 1, and that claims 8—20 are allowable due to their dependency from claim 7. App. Br. 12. As we sustain the rejection of claims 1 and 7, these arguments are not persuasive. Accordingly, we sustain the rejection of claims 2—6 and 8—20. DECISION We AFFIRM the rejection of claims 1—20. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l)(iv). AFFIRMED 10 Copy with citationCopy as parenthetical citation